Financials
Financial year 2025
Exeltis Belgium from Brussel, company number BE0628846248, closed financial year 2025 with a result of € 3,213 after tax. For that financial year Exeltis Belgium recorded a gross margin of € 1.3 million and equity of € 217,429. Compared with financial year 2024, the result moved from € 6,681 to € 3,213. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 23, 2026.
€ 217,429
▲ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3,213
▼ 52% vs 2024
Profit after tax over the fiscal year.
€ 0
▼ 100% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -1,121.
People and assets in 2025
8.7
▲ 0.9 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.2 million
▲ 17% vs 2024
€ 137,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,552
▼ 55% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 81,960
Loans from banks and other lenders, long and short.
€ 147,657
▲ 27% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 319,613
▲ 10% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 848,612 | € 983,447 | € 1,073,669 | € 1,254,901 | ▲ 17% |
| Profit after taxes | € -2,956 | € -6,408 | € 6,681 | € 3,213 | ▼ 52% |
| Equity | € 213,944 | € 207,536 | € 214,217 | € 217,429 | ▲ 1% |
| Total debts | € 401,267 | € 377,305 | € 406,892 | € 549,230 | ▲ 35% |
| Cash | € 34,449 | € 16,646 | € 32,084 | € 0 | ▼ 100% |
| Retained profit | € -4,606 | € -11,014 | € -4,333 | € -1,121 | ▲ € 3,213 |
| Bank debt | € 7,634 | € 0 | € 0 | € 81,960 | |
| Balance sheet total | € 615,211 | € 584,840 | € 621,109 | € 766,660 | ▲ 23% |
| Employees (FTE) | 7.6 | 7.8 | 7.8 | 8.7 | ▲ 0.9 |
By gross margin, Exeltis Belgium ranks 4th of 22 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Brussel that publish figures (fiscal year 2025).
Key figures of Exeltis Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Exeltis Belgium the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Exeltis Belgium?
What happened at Exeltis Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 3,213 (▼ 52% vs 2024). filed late Source: NBB ↗
- Cedric Charroin became a director. NBB
- Piotr Wojczuk became a director. NBB
- Capital increase of € 200,000, published in the Gazette. Source: Staatsblad ↗
- New establishment in Brussel. KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- Ignacio Ponce Gutierrez became a director. NBB
In short
From € 2,956 loss in 2022 to € 3,213 profit in 2025.
Paid € 130,613 in corporate taxes since 2022.
Best year ever: 2024, with € 6,681 profit.
On average € 144,200 of value added per employee in 2025.
Management
Behind Exeltis Belgium are Cedric Charroin, Piotr Wojczuk and Ignacio Ponce Gutierrez.
Directors
According to the 2025 annual accounts
Cedric Charroin
Director
since 2022
Piotr Wojczuk
Director
since 2022
Ignacio Ponce Gutierrez
Director
since 2015
Establishments
Establishment units
Physical locations of this company
Troonstraat 4
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →Association des copropriétaires de l'immeuble à Bruxelles , rue du Trone 4
EDFI Management Company
€ 7.1 million gross margin · 2025
Joint Programming Initiative on Healthy and Productive Seas and Oceans
€ 358,305 gross margin · 2025
European Conservatives and Reformists Party
€ 727,381 gross margin · 2025
New Direction - the Foundation for European Conservatism
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Brussel
Same main activity (Groothandel in farmaceutische en medische artikelen), 30 active companies in Brussel, largest first.
€ 326.9 million revenue · 2025
€ 294.3 million revenue · 2025
VERTEX PHARMACEUTICALS (BELGIUM)
€ 88.9 million revenue · 2025
€ 71.3 million revenue · 2025
€ 20.8 million revenue · 2025
€ 18.7 million revenue · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Exeltis Pharmaceuticals Holding, S.L.(oprichter) 100%
- EXELTIS HEALTHCARE, S.L.(oprichter) 0%
Details
- Company number
- 0628.846.248
- VAT number
- BE 0628.846.248
- Registered office
- Troonstraat 4, 1000 Brussel
- Names & denominations
- Exeltis Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 April 2015
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Markt- en opinieonderzoek